FORHUMANITY Information

ForHumanity Health is pioneering a new frontier in precision medicine — transforming how proven drugs are delivered, experienced, and trusted. Our platform unites pharmaceutical innovation, telehealth access, and nutraceutical science to create faster, safer, and more effective therapies designed for real human outcomes. Through proprietary microencapsulation and dry-powder inhalation technologies, ForHumanity reformulates FDA-approved molecules into rapid-onset therapeutics that outperform traditional oral medications. Our first three products — VigorAir™ (inhaled sildenafil for men’s health), ZapMigraine™ (inhaled eletriptan for migraine relief), and MetaChew™ (metformin gummy for metabolic health and longevity) — empower patients in key areas of vitality, pain management, and metabolic wellness, prioritizing speed, safety, and adherence. Behind ForHumanity is a world-class team from Harvard, Auspex Pharmaceuticals, CrowdStrike, and Sonos, combining deep expertise in molecular science, AI, and scalable telehealth operations. By integrating prescription inhalables, advanced supplements, and physician-guided telemedicine into a single ecosystem, ForHumanity is redefining the patient experience — from diagnosis to daily vitality. Our mission, “Medicine for the People,” reflects a belief that healthcare should be both scientifically advanced and profoundly human. With a defensible IP portfolio, vertically integrated partnerships, and a data-driven go-to-market strategy, ForHumanity Health is building not just a company — but a movement toward more personal, intelligent, and regenerative medicine.